Please feel free forward to your colleagues and share the news of our journal |  Indexed in: PubMed/MEDLINE Web of Science Scopus | REVIEW ARTICLES
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update – Open Access
McFarthing, Kevin | Rafaloff, Gary | Baptista, Marco A.S. | Wyse, Richard K. | Stott, Simon R. W. Non-Genetic Risk Factors for Parkinson’s Disease: An Overview of 46 Systematic Reviews – Open Access
Chen, Yancong | Sun, Xuemei | Lin, Yali | Zhang, Zixuan | Gao, Yinyan | Wu, Irene X.Y. Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease – Open Access
Doppler, Kathrin Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson’s Disease – Open Access
Marie, Anaıs | Darricau, Morgane | Touyarot, Katia | Parr-Brownlie, Louise C. | Bosch-Bouju, Clémentine Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review – Open Access
Suzuki, Keisuke SYSTEMATIC REVIEW
Respiratory Disorders in Parkinson’s Disease
Guilherme, Evelyn M. | Moreira, Roberta de Fátima Carreira | de Oliveira, Adriele | Ferro, Alyne Montero | Di Lorenzo, Valéria A. Pires | Gianlorenço, Anna Carolyna L. POSITION PAPERS
A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and Care – Open Access
Siddiqi, Bernadette | Koemeter-Cox, Andrew Stem Cell-Derived Dopamine Neurons: Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson’s Disease? – Openly Available
Barker, Roger A. | Björklund, Anders | Frucht, Steven J. | Svendsen, Clive N. COVID-19 CONTENT
Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson’s Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture – Openly Available
Suzuki, Keisuke | Numao, Ayaka | Komagamine, Tomoko | Haruyama, Yasuo | Kawasaki, Akiko | Funakoshi, Kei | Fujita, Hiroaki | Suzuki, Shiho | Okamura, Madoka | Shiina, Tomohiko | Hirata, Koichi Barriers to Vaccination Among People with Parkinson’s Disease and Implications for COVID-19 – Openly Available
Phanhdone, Tiffany | Drummond, Patrick | Meisel, Talia | Friede, Naomi | Di Rocco, Alessandro | Chodosh, Joshua | Fleisher, Jori Negative Effects of COVID-19 Stay-at-Home Mandates on Physical Intervention Outcomes: A Preliminary Study – Openly Available
Templeton, John Michael | Poellabauer, Christian | Schneider, Sandra RESEARCH ARTICLES
Estimates of Intracellular Dopamine in Parkinson’s Disease: A Systematic Review and Meta-Analysis – Open Access
Sackner-Bernstein, Jonathan GDNF Therapy: Can We Make It Work?
Björklund, Anders Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats – Open Access
Renko, Juho-Matti | Mahato, Arun Kumar | Visnapuu, Tanel | Valkonen, Konsta | Karelson, Mati | Voutilainen, Merja H. | Saarma, Mart | Tuominen, Raimo K. | Sidorova, Yulia A. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex – Open Access
Boutros, Sydney Weber | Raber, Jacob | Unni, Vivek K. | Most Read JPD Articles in Q2 2021 Listing articles published only in 2020 and 2021 so you can read the most popular recent content | COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the Tunnel? – Open Access (Article Commentary in Vol.11, Iss.1, 2021) (View Press Release)
Bloem, Bastiaan R. | Trenkwalder, Claudia | Sanchez-Ferro, Alvaro | Kalia, Lorraine V. | Alcalay, Roy | Chiang, Han-Lin | Kang, Un Jung | Goetz, Christopher | Brundin, Patrik | Papa, Stella M. Parkinsonism as a Third Wave of the COVID-19 Pandemic? – Open Access (Research Article in Vol.10, Iss.4, 2020)
Beauchamp, Leah C. | Finkelstein, David I. | Bush, Ashley I. | Evans, Andrew H. | Barnham, Kevin J. Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020 – Open Access (Review Article in Vol.10, Iss.3, 2020)
McFarthing, Kevin | Buff, Sue | Rafaloff, Gary | Dominey, Thea | Wyse, Richard K. | Stott, Simon R.W. Parkinson’s Disease and the COVID-19 Pandemic – Open Access (Review Article in Vol.11, Iss.2, 2021)
Fearon, Conor | Fasano, Alfonso Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations – Open Access (Systematic Review in Vol.11, Iss.2, 2021)
Mestre, Tiago A. | Fereshtehnejad, Seyed-Mohammad | Berg, Daniela | Bohnen, Nicolaas I. | Dujardin, Kathy | Erro, Roberto | Espay, Alberto J. | Halliday, Glenda | van Hilten, Jacobus J. | et al. | Genetic Markers Webinar: Watch the Recording! As part of the Quarterly Parkinson's Webinar Series, delivered by Cure Parkinson's and the Journal of Parkinson's Disease , the discussion of specific research topics is brought into the open. Our latest webinar took place on August 4, 2021 and was on the topic of: Genetic Markers and the Progression of Parkinson's. The panel included chair Patrik Brundin (Van Andel Institute, USA) in conversation with Mark R. Cookson (NIH, USA) (investigator of the effects of mutations associated with PD on protein function), Clemens Scherzer (Harvard) (investigating PD through genetics and big data), Stephen Mullin (University of Plymouth, UK) (researching the genetic and clinical stratification of the risk of PD), and advocate for research Jessi Keavney (USA) (carrier of the LRRK2 mutation). Watch recording of the recent webinar via the banner below: | World Parkinson Coalition: News Upcoming Events | The World Parkinson Coalition (WPC) has the next event in the WPC Research Spotlight series happening next month. Details below. Does PD Start in the Gut or the Brain?
September 1, 2021 | Online 11:00 ET | 16:00 BST | 17:00 CEST About: Join this event to hear Professor Per Borghammer, MD, PhD, DMSc, discussing his research looking at where Parkinson’s starts, the gut or the brain, and how it may impact future research. | If you know any colleagues and fellow researchers who are not signed up to receive the newsletter, we invite you to share this mailing with them. They can sign up at: tiny.cc/JPDsignup Also, if you are not already, be sure to follow us on Twitter and find us on Facebook for news related to JPD and PD research. Be part of the discussion! | You are receiving this mailing as you are signed up to receive news from JPD.
You can unsubscibe or alter your preferences at any time by clicking the links below. | |
